M&A Deal Summary |
|
|---|---|
| Date | 2024-01-31 |
| Target | Leon Pharm |
| Sector | Life Science |
| Buyer(s) | InterCure |
| Deal Type | Add-on Acquisition |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 1994 |
| Sector | Agriculture |
| Employees | 75 |
| Revenue | 65M ILS (2020) |
InterCure engages in the research, cultivation, production, marketing, and distribution of cannabis products for medical use in Israel and internationally. It also invests in bioscience, life sciences, medical equipment, and biotechnology sectors. InterCure was founded in 1994 and is based in Herzliya, Israel.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 2 |
| Sector (Life Science) | 1 of 1 |
| Type (Add-on Acquisition) | 2 of 2 |
| Country (Israel) | 2 of 2 |
| Year (2024) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-02-16 |
Better
Tel-Aviv, Israel Better is a pharmaceutical-grade medical cannabis company that has been developing, growing, and marketing cannabis strains dedicated to conditions and indications such as epilepsy, autism, chronic pain, and cancer, and treats tens of thousands of patients every month. Since its inception, the company has been at the forefront of the medical cannabis field and has provided hundreds of thousands of documented treatments - a proven unique therapeutic data. It operates two cultivation spaces with a commercial growth potential of over 3 tons of medical cannabis a year from unique, stable cannabis strains. Better was formed in 2008 and is based in Tel-Aviv, Israel. |
Buy | $35M |
